FRESENIUS MEDICAL CARE-ADR (FMS) Stock Fundamental Analysis
USA - New York Stock Exchange - NYSE:FMS - US3580291066 - ADR
21.68 USD
+0.57 (+2.7%)
21.68 USD
0 (0%)
We assign a fundamental rating of 5 out of 10 to FMS. FMS was compared to 102 industry peers in the Health Care Providers & Services industry. FMS has an average financial health and profitability rating. FMS is valued quite cheap, while showing a decent growth score. This is a good combination!
1. Profitability
1.1 Basic Checks
- FMS had positive earnings in the past year.
- In the past year FMS had a positive cash flow from operations.
- In the past 5 years FMS has always been profitable.
- In the past 5 years FMS always reported a positive cash flow from operatings.
1.2 Ratios
- With a Return On Assets value of 2.33%, FMS perfoms like the industry average, outperforming 59.80% of the companies in the same industry.
- FMS has a better Return On Equity (5.55%) than 61.76% of its industry peers.
- With a Return On Invested Capital value of 3.95%, FMS perfoms like the industry average, outperforming 50.00% of the companies in the same industry.
- Measured over the past 3 years, the Average Return On Invested Capital for FMS is significantly below the industry average of 9.21%.
- The 3 year average ROIC (3.14%) for FMS is below the current ROIC(3.95%), indicating increased profibility in the last year.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 2.33% | ||
| ROE | 5.55% | ||
| ROIC | 3.95% |
ROA(3y)1.65%
ROA(5y)2.29%
ROE(3y)4.06%
ROE(5y)6.04%
ROIC(3y)3.14%
ROIC(5y)4%
1.3 Margins
- FMS has a better Profit Margin (3.66%) than 73.53% of its industry peers.
- In the last couple of years the Profit Margin of FMS has declined.
- Looking at the Operating Margin, with a value of 7.19%, FMS is in the better half of the industry, outperforming 72.55% of the companies in the same industry.
- FMS's Operating Margin has declined in the last couple of years.
- With a Gross Margin value of 25.00%, FMS perfoms like the industry average, outperforming 51.96% of the companies in the same industry.
- In the last couple of years the Gross Margin of FMS has declined.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 7.19% | ||
| PM (TTM) | 3.66% | ||
| GM | 25% |
OM growth 3Y-13.44%
OM growth 5Y-12.95%
PM growth 3Y-20.33%
PM growth 5Y-16.53%
GM growth 3Y-3.16%
GM growth 5Y-4.44%
2. Health
2.1 Basic Checks
- With a Return on Invested Capital (ROIC) below the Cost of Capital (WACC), FMS is destroying value.
- The number of shares outstanding for FMS remains at a similar level compared to 1 year ago.
- The number of shares outstanding for FMS has been reduced compared to 5 years ago.
- Compared to 1 year ago, FMS has an improved debt to assets ratio.
2.2 Solvency
- FMS has an Altman-Z score of 1.76. This is a bad value and indicates that FMS is not financially healthy and even has some risk of bankruptcy.
- FMS has a Altman-Z score (1.76) which is comparable to the rest of the industry.
- The Debt to FCF ratio of FMS is 5.97, which is a neutral value as it means it would take FMS, 5.97 years of fcf income to pay off all of its debts.
- The Debt to FCF ratio of FMS (5.97) is better than 61.76% of its industry peers.
- A Debt/Equity ratio of 0.73 indicates that FMS is somewhat dependend on debt financing.
- FMS has a Debt to Equity ratio of 0.73. This is comparable to the rest of the industry: FMS outperforms 52.94% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.73 | ||
| Debt/FCF | 5.97 | ||
| Altman-Z | 1.76 |
ROIC/WACC0.79
WACC5.02%
2.3 Liquidity
- FMS has a Current Ratio of 1.36. This is a normal value and indicates that FMS is financially healthy and should not expect problems in meeting its short term obligations.
- Looking at the Current ratio, with a value of 1.36, FMS is in line with its industry, outperforming 50.98% of the companies in the same industry.
- FMS has a Quick Ratio of 1.36. This is a bad value and indicates that FMS is not financially healthy enough and could expect problems in meeting its short term obligations.
- With a Quick ratio value of 1.00, FMS is not doing good in the industry: 64.71% of the companies in the same industry are doing better.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 1.36 | ||
| Quick Ratio | 1 |
3. Growth
3.1 Past
- The Earnings Per Share has grown by an nice 16.77% over the past year.
- FMS shows a decrease in Earnings Per Share. Measured over the last years, the EPS has been decreasing by -6.43% yearly.
- The Revenue has been growing slightly by 2.10% in the past year.
- FMS shows a small growth in Revenue. Measured over the last years, the Revenue has been growing by 2.04% yearly.
EPS 1Y (TTM)16.77%
EPS 3Y-1.97%
EPS 5Y-6.43%
EPS Q2Q%34.15%
Revenue 1Y (TTM)2.1%
Revenue growth 3Y3.15%
Revenue growth 5Y2.04%
Sales Q2Q%2.63%
3.2 Future
- Based on estimates for the next years, FMS will show a quite strong growth in Earnings Per Share. The EPS will grow by 12.37% on average per year.
- Based on estimates for the next years, FMS will show a small growth in Revenue. The Revenue will grow by 3.81% on average per year.
EPS Next Y21.73%
EPS Next 2Y12.96%
EPS Next 3Y13.16%
EPS Next 5Y12.37%
Revenue Next Year1.57%
Revenue Next 2Y2.26%
Revenue Next 3Y2.91%
Revenue Next 5Y3.81%
3.3 Evolution
- The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
- When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
4. Valuation
4.1 Price/Earnings Ratio
- The Price/Earnings ratio is 9.85, which indicates a very decent valuation of FMS.
- FMS's Price/Earnings ratio is rather cheap when compared to the industry. FMS is cheaper than 93.14% of the companies in the same industry.
- Compared to an average S&P500 Price/Earnings ratio of 26.94, FMS is valued rather cheaply.
- With a Price/Forward Earnings ratio of 8.96, the valuation of FMS can be described as very reasonable.
- Based on the Price/Forward Earnings ratio, FMS is valued cheaper than 91.18% of the companies in the same industry.
- The average S&P500 Price/Forward Earnings ratio is at 23.94. FMS is valued rather cheaply when compared to this.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 9.85 | ||
| Fwd PE | 8.96 |
4.2 Price Multiples
- Based on the Enterprise Value to EBITDA ratio, FMS is valued cheaper than 89.22% of the companies in the same industry.
- FMS's Price/Free Cash Flow ratio is rather cheap when compared to the industry. FMS is cheaper than 95.10% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 6.18 | ||
| EV/EBITDA | 6.17 |
4.3 Compensation for Growth
- FMS's low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
- A more expensive valuation may be justified as FMS's earnings are expected to grow with 13.16% in the coming years.
PEG (NY)0.45
PEG (5Y)N/A
EPS Next 2Y12.96%
EPS Next 3Y13.16%
5. Dividend
5.1 Amount
- FMS has a Yearly Dividend Yield of 3.90%. Purely for dividend investing, there may be better candidates out there.
- The stock price of FMS dropped by -20.41% in the last 3 months. With lower prices the dividend yield is higher, but it may be a sign investors do not trust the long term dividend.
- FMS's Dividend Yield is rather good when compared to the industry average which is at 0.59. FMS pays more dividend than 99.02% of the companies in the same industry.
- Compared to an average S&P500 Dividend Yield of 1.83, FMS pays a better dividend.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 3.9% |
5.2 History
- The dividend of FMS has a limited annual growth rate of 0.31%.
- FMS has paid a dividend for at least 10 years, which is a reliable track record.
- The dividend of FMS decreased in the last 3 years.
Dividend Growth(5Y)0.31%
Div Incr Years2
Div Non Decr Years2
5.3 Sustainability
- 58.83% of the earnings are spent on dividend by FMS. This is a bit on the high side, but may be sustainable.
- FMS's earnings are growing more than its dividend. This makes the dividend growth sustainable.
DP58.83%
EPS Next 2Y12.96%
EPS Next 3Y13.16%
21.68
+0.57 (+2.7%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Providers & Services
Earnings (Last)11-04 2025-11-04/bmo
Earnings (Next)02-24 2026-02-24/amc
Inst Owners43.91%
Inst Owner Change0%
Ins OwnersN/A
Ins Owner ChangeN/A
Market Cap12.72B
Revenue(TTM)19.64B
Net Income(TTM)718.19M
Analysts57.86
Price Target27.89 (28.64%)
Short Float %0.43%
Short Ratio3.38
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 3.9% |
Yearly Dividend0.69
Dividend Growth(5Y)0.31%
DP58.83%
Div Incr Years2
Div Non Decr Years2
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)14.52%
Min EPS beat(2)14.16%
Max EPS beat(2)14.89%
EPS beat(4)4
Avg EPS beat(4)17.81%
Min EPS beat(4)14.16%
Max EPS beat(4)27.17%
EPS beat(8)7
Avg EPS beat(8)16.37%
EPS beat(12)10
Avg EPS beat(12)13.79%
EPS beat(16)12
Avg EPS beat(16)10.84%
Revenue beat(2)0
Avg Revenue beat(2)-2.52%
Min Revenue beat(2)-3.33%
Max Revenue beat(2)-1.71%
Revenue beat(4)2
Avg Revenue beat(4)0.94%
Min Revenue beat(4)-3.33%
Max Revenue beat(4)6.05%
Revenue beat(8)3
Avg Revenue beat(8)-0.62%
Revenue beat(12)4
Avg Revenue beat(12)-0.64%
Revenue beat(16)6
Avg Revenue beat(16)-0.51%
PT rev (1m)0.01%
PT rev (3m)-5.41%
EPS NQ rev (1m)0%
EPS NQ rev (3m)-6.06%
EPS NY rev (1m)0.17%
EPS NY rev (3m)2.91%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)0.58%
Revenue NY rev (1m)0.01%
Revenue NY rev (3m)0.29%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 9.85 | ||
| Fwd PE | 8.96 | ||
| P/S | 0.55 | ||
| P/FCF | 6.18 | ||
| P/OCF | 4.32 | ||
| P/B | 0.84 | ||
| P/tB | N/A | ||
| EV/EBITDA | 6.17 |
EPS(TTM)2.2
EY10.15%
EPS(NY)2.42
Fwd EY11.17%
FCF(TTM)3.51
FCFY16.18%
OCF(TTM)5.02
OCFY23.15%
SpS39.26
BVpS25.88
TBVpS-3.77
PEG (NY)0.45
PEG (5Y)N/A
Graham Number35.79
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 2.33% | ||
| ROE | 5.55% | ||
| ROCE | 5.62% | ||
| ROIC | 3.95% | ||
| ROICexc | 4.26% | ||
| ROICexgc | 11.65% | ||
| OM | 7.19% | ||
| PM (TTM) | 3.66% | ||
| GM | 25% | ||
| FCFM | 8.93% |
ROA(3y)1.65%
ROA(5y)2.29%
ROE(3y)4.06%
ROE(5y)6.04%
ROIC(3y)3.14%
ROIC(5y)4%
ROICexc(3y)3.31%
ROICexc(5y)4.22%
ROICexgc(3y)8.52%
ROICexgc(5y)10.56%
ROCE(3y)4.51%
ROCE(5y)5.77%
ROICexgc growth 3Y-7.67%
ROICexgc growth 5Y-10.05%
ROICexc growth 3Y-10.35%
ROICexc growth 5Y-11.48%
OM growth 3Y-13.44%
OM growth 5Y-12.95%
PM growth 3Y-20.33%
PM growth 5Y-16.53%
GM growth 3Y-3.16%
GM growth 5Y-4.44%
F-Score5
Asset Turnover0.64
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.73 | ||
| Debt/FCF | 5.97 | ||
| Debt/EBITDA | 3.12 | ||
| Cap/Depr | 47.15% | ||
| Cap/Sales | 3.85% | ||
| Interest Coverage | 3.87 | ||
| Cash Conversion | 83.24% | ||
| Profit Quality | 244.33% | ||
| Current Ratio | 1.36 | ||
| Quick Ratio | 1 | ||
| Altman-Z | 1.76 |
F-Score5
WACC5.02%
ROIC/WACC0.79
Cap/Depr(3y)41.32%
Cap/Depr(5y)47.87%
Cap/Sales(3y)3.79%
Cap/Sales(5y)4.49%
Profit Quality(3y)300.36%
Profit Quality(5y)267.36%
High Growth Momentum
Growth
EPS 1Y (TTM)16.77%
EPS 3Y-1.97%
EPS 5Y-6.43%
EPS Q2Q%34.15%
EPS Next Y21.73%
EPS Next 2Y12.96%
EPS Next 3Y13.16%
EPS Next 5Y12.37%
Revenue 1Y (TTM)2.1%
Revenue growth 3Y3.15%
Revenue growth 5Y2.04%
Sales Q2Q%2.63%
Revenue Next Year1.57%
Revenue Next 2Y2.26%
Revenue Next 3Y2.91%
Revenue Next 5Y3.81%
EBIT growth 1Y-3.43%
EBIT growth 3Y-10.72%
EBIT growth 5Y-11.17%
EBIT Next Year96.22%
EBIT Next 3Y29.78%
EBIT Next 5Y18.33%
FCF growth 1Y-5.89%
FCF growth 3Y1.25%
FCF growth 5Y3.45%
OCF growth 1Y0.06%
OCF growth 3Y-1.4%
OCF growth 5Y-1.45%
FRESENIUS MEDICAL CARE-ADR / FMS FAQ
What is the fundamental rating for FMS stock?
ChartMill assigns a fundamental rating of 5 / 10 to FMS.
Can you provide the valuation status for FRESENIUS MEDICAL CARE-ADR?
ChartMill assigns a valuation rating of 8 / 10 to FRESENIUS MEDICAL CARE-ADR (FMS). This can be considered as Undervalued.
What is the profitability of FMS stock?
FRESENIUS MEDICAL CARE-ADR (FMS) has a profitability rating of 5 / 10.
What is the expected EPS growth for FRESENIUS MEDICAL CARE-ADR (FMS) stock?
The Earnings per Share (EPS) of FRESENIUS MEDICAL CARE-ADR (FMS) is expected to grow by 21.73% in the next year.
Is the dividend of FRESENIUS MEDICAL CARE-ADR sustainable?
The dividend rating of FRESENIUS MEDICAL CARE-ADR (FMS) is 6 / 10 and the dividend payout ratio is 58.83%.